GMAB - Genmab - ADR
IEX Last Trade
27.81
0 0%
Share volume: 341,583
Last Updated: Fri 30 Aug 2024 09:59:57 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$27.81
0.00
0.00%
Summary score
43%
Profitability
55%
Dept financing
2%
Liquidity
50%
Performance
40%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
6.09%
Return on assets
6.05%
Return on sales
0%
Return on invested capital
-36.39%
Total debt ratio
7.04%
Debt ratio change over timeo
-0.87%
Current Ratio
15.71%
Quick Ratio
0%
Cash Position Ratio
3.09%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
8.78%
Return on assets
9.66%
Return on sales
0%
Return on invested capital
17.9%
Total debt ratio
8.22%
Debt ratio change over timeo
-0.81%
Current Ratio
15.54%
Quick Ratio
0%
Cash Position Ratio
5.41%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
18.52%
Return on assets
21.31%
Return on sales
0%
Return on invested capital
-708.79%
Total debt ratio
13.6%
Debt ratio change over time
-0.76%
Current Ratio
9.53%
Quick Ratio
0%
Cash Position Ratio
3.29%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-82.03%
Return on assets
-85.19%
Return on sales
0%
Return on invested capital
465.34%
Total debt ratio
-87.04%
Debt ratio change over time
-0.87%
Current Ratio
41.58%
Quick Ratio
0%
Cash Position Ratio
8.19%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | GMAB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 6.09% | -3.05% | 11.55% | 6.27% |
| Return on assets | 6.05% | 3.6% | 3.57% | 5.27% |
| Return on sales | 0% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -36.39% | 5.09% | 7.99% | 13.19% |
| Profitability | 38% | 44% | 80% | 80% |
| Total debt ratio | 7.04% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -0.87% | 6.09% | 6.03% | 1.53% |
| Dept financing | 2% | 50% | 43% | 14% |
| Current Ratio | 15.54% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 5.41% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 19% | 36% | 39% |
| Short-term ratios | GMAB | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 8.78% | -25.62% | 17.94% | 7.14% |
| Return on assets | 9.66% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | 17.9% | 8.14% | 7.17% | 18.16% |
| Profitability | 62% | 40% | 69% | 70% |
| Total debt ratio | 8.22% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -0.81% | -23.44% | 9.66% | 0.6% |
| Dept financing | 2% | 25% | 45% | 8% |
| Current Ratio | 15.54% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 5.41% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 27% | 22% | 38% |